Exponent (EXPO)
Engineering and scientific consulting for product safety, failures, disputes, health, and environmental risk.
$66.22
After hours−0.06 (−0.09%)
At close$66.28(−1.25%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Jan 2025 | Q1 FY25Apr 2025 | Q2 FY25Jul 2025 | Q3 FY25Oct 2025 | Q4 FY25Jan 2026 | Q1 FY26Apr 2026 | Q2 FY26Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 125 | 123 | 137 | 141 | 136 | 137 | 146 | 142 | 147 | 147 | 166 | 172 |
| Cost of revenue | 74 | 99 | 90 | 99 | 12 | 104 | 8 | 119 | 110 | 112 | 119 | 136 |
| Gross profit | 51 | 24 | 47 | 42 | 124 | 33 | 137 | 23 | 37 | 36 | 48 | 35 |
| 17 | 6 | 16 | 6 | 98 | 6 | 93 | 6 | 8 | 7 | 6 | 7 | |
| 9 | 85 | 8 | 6 | 5 | 6 | 5 | 6 | 8 | 7 | 6 | 7 | |
| Selling & marketing | 3 | 0 | 3 | −79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 6 | 85 | 6 | 86 | 5 | 6 | 5 | 6 | 8 | 7 | 6 | 7 |
| Other expenses | 8 | −79 | 8 | 0 | 93 | 0 | 88 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 34 | 18 | 31 | 36 | 26 | 27 | 44 | 17 | 29 | 29 | 41 | 28 |
| 0 | 12 | 10 | 4 | 10 | 4 | −7 | 20 | 10 | 5 | 1 | 13 | |
| Interest income | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 |
| Other non-operating income | 0 | −12 | −10 | −4 | −10 | −4 | 7 | −20 | −10 | −5 | −1 | 0 |
| Income before tax | 34 | 30 | 40 | 40 | 36 | 31 | 38 | 37 | 39 | 34 | 42 | 41 |
| Income tax expense | 9 | 9 | 10 | 10 | 10 | 8 | 11 | 10 | 11 | 9 | 13 | 11 |
| Net income from continuing operations | 25 | 21 | 30 | 29 | 26 | 24 | 27 | 27 | 28 | 25 | 30 | 29 |
| Net income | 25 | 21 | 30 | 29 | 26 | 24 | 27 | 27 | 28 | 25 | 30 | 29 |
| EPS, basic | $0.48 | $0.41 | $0.59 | $0.57 | $0.51 | $0.46 | $0.52 | $0.52 | $0.55 | $0.49 | $0.59 | $0.60 |
| EPS, diluted | $0.48 | $0.41 | $0.59 | $0.57 | $0.50 | $0.46 | $0.52 | $0.52 | $0.55 | $0.49 | $0.59 | $0.60 |
| Weighted average shares, basic | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 50 | 50 | 49 |
| Weighted average shares, diluted | 52 | 51 | 51 | 52 | 52 | 52 | 52 | 52 | 51 | 51 | 50 | 49 |
| EBITDA | 36 | 32 | 43 | 42 | 38 | 34 | 40 | 39 | 41 | 37 | 45 | 31 |
| Depreciation & amortization | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| EBIT | 34 | 30 | 40 | 40 | 36 | 31 | 38 | 37 | 39 | 34 | 42 | 28 |
